Article Details

Alkermes Announces First Subject Dosed in Phase 1 Study of ALKS 1140 for the Treatment ...

Retrieved on: 2021-11-11 18:47:22

Tags for this article:

Click the tags to see associated articles and topics

Alkermes Announces First Subject Dosed in Phase 1 Study of ALKS 1140 for the Treatment .... View article details on HISWAI: https://pipelinereview.com/index.php/2021111179652/Small-Molecules/Alkermes-Announces-First-Subject-Dosed-in-Phase-1-Study-of-ALKS-1140-for-the-Treatment-of-Neurodegenerative-and-Neurological-Disorders.html

Excerpt

Alkermes plc is a fully-integrated, global biopharmaceutical company ... PipelineReview.com is powered by La Merie Business Intelligence La Merie ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up